Bill Text: NJ A4044 | 2022-2023 | Regular Session | Introduced
Bill Title: Requires long-term care facilities to stock and provide COVID-19 antiviral treatments to residents.
Spectrum: Partisan Bill (Republican 3-0)
Status: (Introduced - Dead) 2022-05-16 - Introduced, Referred to Assembly Health Committee [A4044 Detail]
Download: New_Jersey-2022-A4044-Introduced.html
Sponsored by:
Assemblyman ROBERT AUTH
District 39 (Bergen and Passaic)
Co-Sponsored by:
Assemblywoman Flynn
SYNOPSIS
Requires long-term care facilities to stock and provide COVID-19 antiviral treatments to residents.
CURRENT VERSION OF TEXT
As introduced.
An Act concerning COVID-19 antiviral treatments in long-term care facilities and supplementing Title 26 of the Revised Statutes.
Be It Enacted by the Senate and General Assembly of the State of New Jersey:
1. a. Each long-term care facility shall maintain an adequate supply of antiviral treatment for COVID-19 on site for its residents. The long-term care facility shall provide any resident, who has tested positive for COVID-19 and is symptomatic, antiviral treatment for COVID-19.
b. As used in this section, "long-term care facility" means a nursing home or assisted living residence licensed pursuant to P.L.1971, 41 c.136 (C.26:2H-1 et seq.).
2. This act shall take effect immediately.
STATEMENT
This bill requires long-term care facilities to stock and provide COVID-19 antiviral treatments to their residents.
Under this bill, a long-term care facility will maintain an adequate supply of antiviral treatment for COVID-19 on site for its residents. The long-term care facility will provide any resident, who has tested positive for COVID-19 and is symptomatic, antiviral treatment for COVID-19. The bill defines "long-term care facility" to mean a nursing home or assisted living residence licensed pursuant to P.L.1971, 41 c.136 (C.26:2H-1 et seq.).
